Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Shares Issued (2016 - 2025)

Lexaria Bioscience's Shares Issued history spans 9 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 20.05% year-over-year to $3.5 million; the TTM value through Nov 2025 reached $7.8 million, up 63.41%, while the annual FY2025 figure was $6.0 million, 0.94% down from the prior year.
  • Shares Issued for Q4 2025 was $3.5 million at Lexaria Bioscience, up from $11720.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.3 million in Q4 2024 and bottomed at -$5.5 million in Q3 2021.
  • The 4-year median for Shares Issued is $11720.0 (2025), against an average of $403114.4.
  • The largest annual shift saw Shares Issued tumbled 11616.42% in 2021 before it soared 660.15% in 2024.
  • A 4-year view of Shares Issued shows it stood at -$5.5 million in 2021, then surged by 110.48% to $571651.0 in 2023, then skyrocketed by 660.15% to $4.3 million in 2024, then dropped by 20.05% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Shares Issued are $3.5 million (Q4 2025), $11720.0 (Q1 2025), and $4.3 million (Q4 2024).